Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Caribou Biosciences (CRBU) over the last 5 years, with Q3 2025 value amounting to $235000.0.

  • Caribou Biosciences' Amortizatization of Intangibles fell 8078.5% to $235000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 444.76%. This contributed to the annual value of $4.7 million for FY2024, which is 680.23% up from last year.
  • As of Q3 2025, Caribou Biosciences' Amortizatization of Intangibles stood at $235000.0, which was down 8078.5% from $293000.0 recorded in Q2 2025.
  • Caribou Biosciences' 5-year Amortizatization of Intangibles high stood at $2.4 million for Q3 2023, and its period low was -$1.6 million during Q4 2023.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $677500.0 (2022), whereas its average is $679750.0.
  • Per our database at Business Quant, Caribou Biosciences' Amortizatization of Intangibles surged by 183653.85% in 2022 and then crashed by 27906.98% in 2023.
  • Caribou Biosciences' Amortizatization of Intangibles (Quarter) stood at -$52000.0 in 2021, then skyrocketed by 1836.54% to $903000.0 in 2022, then tumbled by 279.07% to -$1.6 million in 2023, then surged by 162.96% to $1.0 million in 2024, then plummeted by 76.92% to $235000.0 in 2025.
  • Its Amortizatization of Intangibles was $235000.0 in Q3 2025, compared to $293000.0 in Q2 2025 and $452000.0 in Q1 2025.